title: Continuous IV infusion - Neonatal Intensive Care Drug Manual
text: |
  Neonatal Intensive Care Drug Manual
  |
  bet | 250/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  Continuous IV infusion: Via syringe driver.
  Monitoring
  |
  Blood glucose concentrations, watch for rebound hypoglycaemia after cessation.
  Consider cardiorespiratory and blood pressure monitoring.
  Electrolytes for continuous infusion.
  |
  Contraindications
  |
  Phaeochromocytoma [4-6], glucagonoma.
  Hypersensitivity to glucagon or any component.
  |
  Precautions
  |
  Hypertension.
  Insulinoma: Glucagon has been used to treat hypoglycaemia caused by insulinoma. However, it should be used cautiously because of the propensity to release insulin [7].
  |
  Drug interactions
  |
  Drug interactions largely unreported in newborn infants.
  Glucagon has a positive inotropic action which may counteract effect of beta-blockers. Beta-blockers may reduce hyperglycaemic effect of glucagon [8].
  Warfarin: Increased effect of warfarin resulting in increased risk of bleeding.[9]
  Indomethacin: Glucagon may lose its ability to raise blood glucose or paradoxically may even produce hypoglycaemia [7].
  |
  |
  |
  | |